| Record ID | marc_loc_2016/BooksAll.2016.part18.utf8:154579084:1262 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part18.utf8:154579084:1262?format=raw |
LEADER: 01262pam a2200301 a 4500
001 88007120
003 DLC
005 19880729063321.7
008 880309s1988 ne a b 00100 eng c
010 $a 88007120
020 $a0444429670 (U.S.) :$cfl 525.00 (Netherlands : est.)
040 $aDNLM/DLC$cDLC
050 0 $aRS431.P456$bP47 1988
060 $aW1 BI619MD v. 4$aQD 401 P541
082 0 $a615/.311$219
245 00 $aPhenothiazines and 1,4-benzothiazines :$bchemical and biomedical aspects /$cedited by R.R. Gupta.
260 0 $aAmsterdam ;$aNew York :$bElsevier ;$aNew York, NY, U.S.A. :$bDistributors for the U.S. and Canada, Elsevier Science Pub. Co.,$c1988.
300 $axxii, 992 p. :$bill. ;$c25 cm.
440 0 $aBioactive molecules ;$vv. 4
504 $aIncludes bibliographies and indexes.
650 0 $aPhenothiazine$xDerivatives.
650 0 $aBenzothiazine$xDerivatives.
650 0 $aPhenothiazine$xDerivatives$xTherapeutic use$xTesting.
650 0 $aBenzothiazine$xDerivatives$xTherapeutic use$xTesting.
650 0 $aPhenothiazine$xDerivatives$xStructure-activity relationships.
650 0 $aBenzothiazine$xDerivatives$xStructure-activity relationships.
650 2 $aPhenothiazines.
700 10 $aGupta, R. R.$q(Radha Raman),$d1941-